Marjolein A. van der Pol

High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival

Anna van Rhenen, N Feller, Angèle Kelder et al. · Clinical Cancer Research · 2005 · 370 citations · Full text

Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-κB-mediated increase of intracellular doxorubicin accumulation

Jens van Wijngaarden, Ermond van Beek, Gerda van Rossum et al. · European Journal of Cancer · 2006 · 75 citations

Inflammation, Tumor Biology, Chemoprevention Strategy +12

Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis‐corrected P‐glycoprotein function in clinical samples

Marjolein A. van der Pol, Henk J. Broxterman, Guus Westra et al. · Cytometry Part B Clinical Cytometry · 2003 · 40 citations · Full text

Immunologic Purging of Autologous Peripheral Blood Stem Cell Products Based on CD34 and CD133 Expression Can Be Effectively and Safely Applied in Half of the Acute Myeloid Leukemia Patients

N Feller, Marjolein A. van der Pol, Taco Waaijman et al. · Clinical Cancer Research · 2005 · 29 citations · Full text

Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival

Bijan Moshaver, Marjolein A. van der Pol, August H. Westra et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 23 citations